Multi-omics integration analysis identifies novel genes for alcoholism with potential overlap with neurodegenerative diseases.
- Authors
- Kapoor, Manav; Chao, Michael J; Johnson, Emma C; Novikova, Gloriia; Lai, Dongbing; Meyers, Jacquelyn L; Schulman, Jessica; Nurnberger, John I; Porjesz, Bernice; Liu, Yunlong; Collaborative Study on the Genetics of Alcoholism (COGA); Foroud, Tatiana; Edenberg, Howard J; Marcora, Edoardo; Agrawal, Arpana; Goate, Alison
- Year
- 2021
- Journal
- Nature communications
- PMID
- 34417470
- DOI
- 10.1038/s41467-021-25392-y
- PMCID
- PMC8379159
Identification of causal variants and genes underlying genome-wide association study (GWAS) loci is essential to understand the biology of alcohol use disorder (AUD) and drinks per week (DPW). Multi-omics integration approaches have shown potential for fine mapping complex loci to obtain biological insights to disease mechanisms. In this study, we use multi-omics approaches, to fine-map AUD and DPW associations at single SNP resolution to demonstrate that rs56030824 on chromosome 11 significantly reduces SPI1 mRNA expression in myeloid cells and lowers risk for AUD and DPW. Our analysis also identifies MAPT as a candidate causal gene specifically associated with DPW. Genes prioritized in this study show overlap with causal genes associated with neurodegenerative disorders. Multi-omics integration analyses highlight, genetic similarities and differences between alcohol intake and disordered drinking, suggesting molecular heterogeneity that might inform future targeted functional and cross-species studies.
Overview of the study.Series of analyses were undertaken to identify the candidate causal genes associated with risk of AUD and DPW. We used the stratified linkage disequilibrium score (LDSC) regression to test whether the heritability of AUD and DPW is enriched in regions surrounding genes with chromatin markers in a specific tissue. This analysis helped us to identify the large eQTL/mQTLs datasets in the relevant tissues to perform the multi-omic integration analysis using SMR. The candidate causal SNPs and genes prioritized using SMR were further filtered according to threshold of association in GWAS and linkage disequlibrium (Heidi P and COJO). The complex loci with multiple genes were further validated and prioritized by exploring differential gene expression data from brains of people with alcohol use disorder and controls. Integration of eQTL data from monocytes also helped to prioritize candidate genes specifically expressed in the myeloid cells. The cell type specific epigenetic data from the human brain was also used to identify the causal SNP/s associated with DPW and AUD.
LDSC analysis using tissue specific chromatin data.LDSC analysis showed significant enrichment of promoter-specific markers (H3K4me1/me3) in the fetal and adult brain for the SNPs identified in (A) DPW and (B) AUD GWAS meta-analysis. Y-axis represents the annotations and X-axis represents the −log 10 P value for enrichment calculated using partition heritability method as implemented in LDSC. The dotted red line represents the threshold of multiple test correction according to Bonferroni.
Results of SMR based integration analysis of DPW and AUD GWAS meta-analysis with eQTL/mQTL from fetal and adult brain.X-axis represents the chromosomes and Y-axis shows the standardized direction of effect (Z scores) of co-localized SNP on gene expression/ methylation and GWAS phenotype. Z scores were derived from the effect size (betas) and standard errors (SE) from the SMR analyses. Positive Z score shows that increase in mRNA expression or methylation is associated with excessive drinking or increased risk of AUD, while negative Z score depicts the vice-versa. Genes marked on the plots represent the genes that passed the strict threshold of co-localization (FDR SMR-P < 20%; SMRHeidi P > 0.05; GWAS P < 5 × 10−5; eQTL P < 5 × 10−8) and multiple levels of transcriptomic and/ or epigenetic evidence. SMR P-values for the co-localized SNPs are obtained using the Wald test.
MAPT was identified as a candidate gene associated with increased DPW.A Locus zoom plot showing DPW and eQTL (DLFPC) associations at 17q.21.3. X-axis represents the positions along chromosome 17 and the y-axis represents the P values of each SNP at this locus. P-values for the DPW GWAS are obtained from aggregated weighted Z statistics (Liu et al, 2019). P-values for DLFPC-eQTL meta-analysis were obtained using conventional inverse-variance-weighted meta-analysis as implemented in the SMR software package. Color of each dot presents the R2 for LD at the locus (Red = 0.8–1.0; Orange 0.6–0.79; Green 0.4–0.59; Blue 0.2–0.39 and dark blue <2.0). B The co-localized SNPs were found to be overlapping with the chromatin interaction region that loops back to the promoter of the MAPT gene. C In independent transcriptomic data from the human brain (N = 92), mRNA expression of MAPT was found to be associated with the alcohol consumption. The analysis was performed using DeSeq2 program and P-value for association resulted from the Wald test. The shaded area around trend-line depicts the 95% confidence level intervals plotted using “geom_smooth(method = “lm”)” from ggplot2.
SPI1 was nominated as candidate gene associated with increased DPW and AUD.A Locus zoom plot showing DPW, AUD, and mQTL (Fetal brain) associations at 11p.11.2. X-axis represents the positions along chromosome 11 and y-axis represents the −log10 (P) values of each SNP at this locus. P-values for the DPW GWAS (Liu et al, 2019) and AUD GWAS are obtained from aggregated weighted Z statistics. P-values for mQTL meta-analysis were obtained using conventional inverse-variance-weighted meta-analysis. Color of each dot presents the R2 for LD at the locus (Red = 0.8–1.0; Orange 0.6–0.79; Green 0.4–0.59; Blue 0.2–0.39 and dark blue <2.0). Yellow line represents the position of rs56030824 identified as a functional variant co-localized with AUD, DPW, and mQTLs in the fetal brain. The tracks show the peaks for promoter marks in 4 major cell types of the brain. Rs56030824 was found to overlap with promoter-specific marks (H3K4me3 and H3K27ac), specifically in microglia. B Effect sizes for DPW GWAS and SPI1 expression in CD14+ monocytes were found to be correlated i.e. decreased alcohol intake was associated with decreased SPI1 expression. Rs56030824 showed the strongest association with DPW and mQTL in the common variant category. The shaded area around trend-line depicts the 95% confidence level intervals plotted using “geom_smooth(method = “lm”)” from ggplot2. C rs56030824 is a strong eQTL and associated with SPI1 expression in CD14+ monocytes. The box in the Box Plot is extending from the 25th percentile to the 75th percentile, with median horizontal line within the box. The whiskers are extending to one and a half times the interquartile range.
No entities extracted from this document yet.
No uploaded files.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Genetically Validated Immune Susceptibility Markers for Crohn's Disease: A Multi-Omics Mendelian Randomization Analysis. | Li Z | — | 2026 | → |
| Host-gut microbial metabolic crosstalk in postpartum depression: A multiomics insight linking blood metabolites to epigenetic modulation. | Zhang Z et al. | — | 2026 | → |
| Integrative multi-omics analyses identify key genes and elucidate bidirectional regulatory mechanisms in thyroid dysfunction. | Hu Y et al. | — | 2026 | → |
| Programmed cell death and risk of diabetic retinopathy: a Mendelian randomization study. | Chen Y et al. | — | 2026 | → |
| Systemic Interplay of BDNF and Serotonin Pathways Defines Behavioral and Molecular Responses to Midbrain 5-HT7 Overexpression and Chronic Ethanol Consumption. | Rodnyy A et al. | — | 2026 | → |
| Advancements in genetic research by the Hispanic Community Health Study/Study of Latinos: A 10-year retrospective review. | Rao H et al. | — | 2025 | → |
| A multi-omics Mendelian randomization study identifies new therapeutic targets for alcohol use disorder and problem drinking. | Rosoff DB et al. | — | 2025 | → |
| Ethanol consumption aggravates amyloid pathology and neuroinflammation in Alzheimer's disease associated with inflammasome activation and ASC speck propagation. | Brezani V et al. | — | 2025 | → |
| Genetic and environmental influences on alcohol consumption in middle to late life. | Gustavson DE et al. | — | 2025 | → |
| Integrated multidimensional bioinformatics analysis of the molecular mechanisms of ulcerative colitis-associated colorectal cancer and MMP1 as a potential therapeutic target. | Yu X et al. | — | 2025 | → |
| Integrated single-cell multiomic profiling of caudate nucleus suggests key mechanisms in alcohol use disorder. | Green NC et al. | — | 2025 | → |
| Multi-omics analysis unraveling stemness features associated with oncogenic dedifferentiation in 12 cancers. | Cheng J et al. | — | 2025 | → |
| Next-generation biomarkers for alcohol consumption and alcohol use disorder diagnosis, prognosis, and treatment: A critical review. | Clark SL et al. | — | 2025 | → |
| Causal effect of gut microbiota on pancreatic cancer: A Mendelian randomization and colocalization study. | Li X et al. | — | 2024 | → |
| Multiomics Evaluation of Human iPSCs and iPSC-Derived Neurons. | Lee GB et al. | — | 2024 | → |
| Prioritization of risk genes in colorectal cancer by integrative analysis of multi-omics data and gene networks. | Zhang M et al. | — | 2024 | → |
| Prioritizing susceptibility genes for the prognosis of male-pattern baldness with transcriptome-wide association study. | Choi E et al. | — | 2024 | → |
| The Effect of Alcohol Consumption on Progressive Supranuclear Palsy: A Cross-Sectional Study. | Tian M et al. | — | 2024 | → |
| Transcriptional Patterns in Stages of Alzheimer's Disease Are Cell-Type-Specific and Partially Converge with the Effects of Alcohol Use Disorder in Humans. | Joshi A et al. | — | 2024 | → |
| 5. Collaborative Study on the Genetics of Alcoholism: Functional genomics. | Gameiro-Ros I et al. | — | 2023 | → |
| Analysis of the brain transcriptome for substance-associated genes: An update on large-scale genome-wide association studies. | Zhao Y et al. | — | 2023 | → |
| Chemical Genetic Identification of PKC Epsilon Substrates in Mouse Brain. | Dugan MP et al. | — | 2023 | → |
| Chronic MAP4343 reverses escalated alcohol drinking in a mouse model of alcohol use disorder. | Macedo GC et al. | — | 2023 | → |
| DNA methylation QTL mapping across diverse human tissues provides molecular links between genetic variation and complex traits. | Oliva M et al. | — | 2023 | → |
| Editorial: Biophysics approaches to investigate multi-organ alcohol-induced damage. | Paloczi J et al. | — | 2023 | → |
| Fetal alcohol spectrum disorders and the risk of crime. | Roozen S et al. | — | 2023 | → |
| Identifying potential risk genes and pathways for neuropsychiatric and substance use disorders using intermediate molecular mediator information. | Gedik H et al. | — | 2023 | → |
| Oxidative stress gene expression, DNA methylation, and gut microbiota interaction trigger Crohn's disease: a multi-omics Mendelian randomization study. | Xu S et al. | — | 2023 | → |
| RNA alternative splicing impacts the risk for alcohol use disorder. | Li R et al. | — | 2023 | → |
| The Collaborative Study on the Genetics of Alcoholism: Overview. | Agrawal A et al. | — | 2023 | → |
| The Genetically Informed Neurobiology of Addiction (GINA) model. | Bogdan R et al. | — | 2023 | → |
| Unraveling Psychiatric Disorders through Neural Single-Cell Transcriptomics Approaches. | Chehimi SN et al. | — | 2023 | → |
| Circadian transcription factor NPAS2 and the NAD<sup>+</sup> -dependent deacetylase SIRT1 interact in the mouse nucleus accumbens and regulate reward. | Becker-Krail DD et al. | — | 2022 | → |
| Differential dysregulation of CREB and synaptic genes in transgenic Drosophila melanogaster expressing shaggy (GSK3), TauWT, or Amyloid-beta | Ataellahi F et al. | — | 2022 | — |
| Gene-based polygenic risk scores analysis of alcohol use disorder in African Americans. | Lai D et al. | — | 2022 | → |
| Gene-environment interactions in Alzheimer disease: the emerging role of epigenetics. | Migliore L et al. | — | 2022 | → |
| Innate immune activation: Parallels in alcohol use disorder and Alzheimer's disease. | Ramos A et al. | — | 2022 | → |
| Long Non-Coding RNAs: The New Frontier into Understanding the Etiology of Alcohol Use Disorder. | Denham AN et al. | — | 2022 | → |
| Pharmacogenetics of human sulfotransferases and impact of amino acid exchange on Phase II drug metabolism. | Isvoran A et al. | — | 2022 | → |
| Shared genetic architecture between the two neurodegenerative diseases: Alzheimer's disease and glaucoma. | Zheng C et al. | — | 2022 | → |